BIO.News Newsletter

Ahead of German Chancellor Angela Merkel’s visit to Washington, BIO sent a letter to her government about how we can collaborate on global vaccine access—we have the scoop. Plus, LanzaTech has a new partnership to produce clothing from carbon. (1,000 words, 5 minutes)

Last week, the U.S. Trade Representative met with Mexican government officials to discuss Mexico’s policy toward biotech crops—we have the readout, plus insights from yesterday’s Senate Judiciary hearing on competition policy for prescription drugs. (807 words, 4 minutes, 2 seconds)

Today, we have a deep dive into a new report on the regulatory framework for gene editing of agricultural animals, as well as three concrete things your company can do right now to improve diversity, equity, and inclusion in the biotech industry. (819 words, 4 minutes, 5 seconds)

We’re back! Today, we look at how far we’ve come on COVID vaccinations and the sustainable aviation fuel legislation we’re watching as Congress returns to the Capitol. We also have headlines you might have missed over the break, plus what to expect this week in Washington. (945 words, 4 minutes, 43 seconds)

Like many of you, Team Good Day BIO is taking a break to enjoy summer—but don’t worry, we’ll be back in your inbox on Monday, July 12, to ensure you don’t miss a beat. In the meantime, if you need something to read or listen to at the beach, by the pool, or just away from your desk, here’s what’s on our list. Take a look and stay on top of the latest biotech news—because there’s a lot to do when we get back. 

Before you head out for the holiday weekend, we have an update on FY22 funding for USDA and FDA, as well as a recap of BIO’s Clinical Trial Diversity Summit with practical things we can do right now to improve trial diversity. (813 words, 4 minutes, 3 seconds) BIO is taking a break for the Fourth of July. Good Day BIO will resume regular publication on Monday, July 12. Enjoy your time with family and friends—and if you haven’t done so yet, it’s a great time to get your COVID vaccine!

It’s a new month—and there’s a lot to do. The Sustainable Skies Act would help combat GHG emissions and temperature rise—but it needs your support. We’re also keeping the pressure on the administration about what we can do to address the global vaccine shortage and why an IP waiver won’t help. (905 words, 4 minutes, 31 seconds)

It’s the one-year anniversary of the U.S.-Mexico-Canada Agreement (USMCA)—but we’re not celebrating yet. We explain why. On the other hand, a new report has us feeling optimistic about the resilience of the U.S. biotech industry and workforce. (859 words, 4 minutes, 17 seconds)

We got great news yesterday about the immune response generated by some of the COVID-19 vaccines—but there’s still work to do. Meanwhile, as heat and drought rage across the western U.S., we look at what it means for agriculture—and how gene editing can offer solutions. (613 words, 3 minutes, 3 seconds)

Start your week with a nutritious, delicious banana—while you still can. Today’s episode of the I am BIO Podcast explores the threat to bananas and what it tells us about our food systems. We also have news on a BARDA decision that would affect R&D of COVID therapeutics as well as the bioeconomy bill moving through Congress. (797 words, 3 minutes, 59 seconds)